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SynthesisAbstract One of the b-adrenergic receptor blocking agents, esmolol, is synthesized in its racemic
(RS) and enantio enriched forms (R and S) by a new chemical and chemo-enzymatic route. The
enantio-pure intermediates (R) and (S)-methyl 3-(4-(3-chloro-2-hydroxypropoxy)phenyl)propano-
ate were synthesized from the corresponding racemic alcohol by enzymatic kinetic resolution.
The commercially available lipases PCL and CRL showed complementary enantioselectivity in
the transesteriﬁcation reaction of racemic alcohol with vinyl acetate as the acyl donor. The reactions
afforded the (R)-alcohol along with (S)-acetate and the (S)-alcohol along with (R)-acetate, respec-
tively, indicating the enzymatic switch for reversal of enantioselectivity. Various reaction parame-
ters such as substrate and enzyme concentration, type of reaction medium, duration of
conversion and enantioselectivity were optimized. The (R)- and (S)-alcohols were converted to
the (S)- and (R)-esmolol, respectively, on N-alkylation with isopropanolamine. The enzymatically
obtained (R)- and (S)-acetates were chemically hydrolyzed to the corresponding alcohols and fur-
ther converted to (S)- and (R)-esmolol by chemical reactions. These represent the new chemo-enzy-
matic synthesis of both the enantiomers of the drug. Using chemical routes, the (RS)/(R)/(S)-
esmolol were also synthesized from (RS)/(R)/(S)-epichlorohydrin via the corresponding (RS)/(S)/
(R)- methyl 3-(4-((oxiran-2-yl)methoxy)phenyl)propanoate and the (RS)/(R)/(S)-methyl 3-(4-(3-
chloro-2-hydroxypropoxy)phenyl)propanoate intermediates. This process has given improved over-
all yield and better enantiomeric excess compared to the reported one.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
For the rapid control of heart rate (HR) and/or blood pressure
(BP) in the critical care unit for a short period of time, esmolol
is a very appropriate drug (Wiest and Haney, 2012). Esmolol is
a unique cardioselective b1-receptor blocking agent with a fast
onset and tiny duration of action (Wiest, 1995). Its efﬁcacy has
been established in a variety of patients, including those with
myocardial ischemia (Edwards et al., 1994; Hartley and
Vaughan, 1993), unstable angina (Anderson et al., 2011;rabian
2 L. Banoth, U.C. BanerjeeBarth et al., 1991), supraventricular arrhythmias (Adamson
et al., 2006; Balser et al., 1998; Garnock-Jones, 2012), peri-
and post-operative tachycardia and hypertension (Tempe
et al., 1999; Wiest et al., 1998) and electroconvulsive therapy
(Van Der Starre et al., 2008; Zvara et al., 1997). Although cur-
rently 1 is marketed as the racemic form, (S)-enantiomer of
esmolol is an eutomer and the (R)-enantiomer is a distomer,
(S)-esmolol as a b-blocker has two times higher potency than
that of (RS)-esmolol (Quon et al., 1988). The limited reports
for the synthesis of 1 are summarized in Scheme 1 (Erhardt
et al., 1982) in which one is Sharpless asymmetric dihydroxyla-
tion (route C) and the other one is hydrolytic kinetic resolution
(route B). The opening of an epoxide ring by amines is the
most common strategy for the synthesis of the 1,2-amino alco-
hol, a class of b1-adrenergic blocking agents (Pujala et al.,
2011; Shivani et al., 2007). Efforts toward this direction for
the synthesis of 1 involve the reaction of isopropylamine with
the requisite epoxide 2-phenylglycidyl ether 2 (Erhardt et al.,Cl O
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such as higher cost of chiral transition metal complex catalysts,
the toxic nature of catalysts, moisture sensitivity, generation of
more by products and tedious separation process. These
reported procedures afforded in overall 16–66% chemical
yield. Herein, we describe new chemical and chemo-enzymatic
synthetic route for (RS)-, (R)-, and (S)-esmolol (route D,
Scheme 1) with improved overall chemical yield (61–76%)
and higher (92–98%) enantiomeric excess.
2. Results and discussion
In the present days context, use of green chemistry tools in the
design of a new synthetic route is highly desirable (Alfonsi
et al., 2008; Roughley and Jordan, 2011) and integrating bio-
catalysis in the synthesis is a graceful approach toward green
chemistry (Clouthier and Pelletier, 2012). Enzymatic kinetic
resolution of various racemic secondary alcohols (AmrutkarO
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New chemical and chemo-enzymatic synthesis of (RS)-, (R)-, and (S)-esmolol 3et al., 2013; Banoth et al., 2009, 2012a,b) encouraged us to
design a new chemo-enzymatic route for (R)- and (S)-esmolol
(Scheme 2).
2.1. Synthesis of (RS)-methyl-3-(4-(3-chloro-2-
hydroxypropoxy)phenyl)propanoate (10)
The starting racemic epoxide (RS)-2 was prepared (yield, 90%)
by the reaction of 3 with (RS)-4 in the presence of K2CO3 in
MeCN under reﬂux using the reported procedure. The treat-
ment of (RS)-2 with acetyl chloride in DCM and water affor-
ded the desired substrate (RS)-10 for lipase catalyzed kinetic
resolution (Scheme 3).
To optimize the experimental condition for the enzymatic
kinetic resolution, it is necessary to have authentic samples
of (R)- and (S)-10 and the corresponding O-acylated deriva-
tives (R)- and (S)-11, respectively.
2.2. Synthesis of authentic(R)/(S)-methyl-3-(4-(3-chloro-2-
hydroxypropoxy)phenyl) propanoate (10) and (RS)/(R)/(S)-
methyl-3-(4-(2-acetoxy-3-chloropropoxy)phenyl) propanoate
(11)
The starting materials (S)- and (R)-2 for the synthesis of the
authentic samples of (R)- and (S)-10 were prepared by the
reaction of 3 with (R)- and (S)-4, respectively, using the mod-
iﬁed method. The optical purity was determined by optical
rotation value and chiral HPLC. As observed in the previous
report, the alkylation using (R)-4 resulted the (S)-2 [89% yield,
95% ee and optical rotation [a]D
20 +4.46 (c 1.0, CHCl3)] andO
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tion [a]D
20 +4.42 (c 1.0, CHCl3)] (Scheme 4). The formation of
(S)-2 from (R)-4 may be due to the nucleophilic ring opening
of the epoxide ring at the least substituted carbon atom of
the epoxide followed by the nucleophilic displacement of the
chlorine atom (Path b, Scheme 4), rather than the direct nucle-
ophilic substitution of the chlorine atom (Path a, Scheme 4).
This is responsible for the observed inversion of conﬁguration.
Ring opening of (S)-2 by acetyl chloride and water follow-
ing the same procedure as used for (RS)-2 afforded (R)-10
(92% yield and 94% ee). Similarly, (S)-10 was obtained from
(R)-2 in 91% yield and 93% ee. The treatment of (RS)-10 with
Ac2O at rt under neat condition in the presence of ZrCl4
(2 mol%) (Chakraborti and Gulhane, 2004) gave the (RS)-11
in 95% yield. Acetylation of (R)-10 and (S)-10 using a similar
procedure resulted in the formation of (R)-11 and (S)-11 (93%
yield and 94% ee and 92% yield and 93% ee, respectively).
2.3. Lipase-catalyzed kinetic resolution of (RS)-10
The best operative enzymatic kinetic resolution method using
various lipases was found out with the substrates (RS)-10
and the authentic samples of (R)/(S)-10 and (R)/(S)-11.
2.3.1. Screening of lipases
The selection of lipase is the ﬁrst step to achieve successful
kinetic resolution of any transesteriﬁcation reaction. Initially,
lipases from different sources [commercially available immobi-
lized lipase in sol–gel-Ak from Pseudomonas cepacia (PCL),
immobilized lipozyme from Mucor miehei (MML), lipaseO
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4 L. Banoth, U.C. Banerjeeacrylic resin from Candida antarctica (CAL), lipase A
C. antarctica (CAL-A), Candida rugosa (CRL L8525),
C. rugosa (CRL L1754), Candida cylindracea (CCL), Aspergillus
niger (ANL), porcine pancreas lipase (PPL), lipase AY
‘‘Amano’’30 (CRL) and laboratory strains 5b1, 5b2, 5a1, 1b1
(N), 5d1, 1b1 (Singh et al., 2012)] were screened for the transeste-
riﬁcation of (RS)-10 with vinyl acetate in toluene (Scheme 5).
The PCL 62274 exhibited best activity for conversion of
(RS)-10 to (R)-10 and (S)-11, respectively. The CRL 62316
exhibited best activity for conversion of (RS)-10 to (S)-10
and (R)-11, respectively. Thus, these enzymes show comple-
mentary action with respect to enantioselectivity. However,
PCL 62274 and CRL 62316 were found to be better in terms
of conversion and enantioselectivity (Table 1).
2.3.2. Selection of organic solvent
The solvent effect on the enantioselectivity of enzymatic reac-
tions has been reviewed in many literatures (Hudson et al.,
2005; Khmelnitsky and Rich, 1999). Lipases have attracted
much attention to organic chemists because of their high sta-
bility in organic solvents (Dordick, 1989; Khmelnitsky et al.,
1988). In the present study several solvents, for instance,
t-butyl methyl ether: log P= 1.35, isooctane: log P= 4.5, tol-
uene: log P= 2.5, chloroform: log P= 2.0, dichloromethane:
log P= 1.25 etc., were investigated for the resolution of (RS)-
10 (Table 2). The effect of solvent on the activity and enanti-
oselectivity of PCL and CRL for kinetic resolution of (RS)-
10 was studied using vinyl acetate as acyl donor at 25 C. It
had been observed that both the reaction rate and enantiose-
lectivity were affected largely by the solvent employed
(Table 2). Toluene for PCL and cyclohexane for CRL were
found to offer maximum enantioselectivity and enantiomericPlease cite this article in press as: Banoth, L., Banerjee, U.C. New chemical
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.03.011excess of substrate and product as compared to the other sol-
vents. It has been reported (Laane et al., 1987) in the literature
that in polar solvents having a log P< 2, the rates of biocata-
lytic reactions are less compared to those of apolar solvents
having a log P> 4. The moderate rates of reactions are
reported in organic solvents with a log P value between 2
and 4 (Laane et al., 1987). It has been reported (Laane et al.,
1987) that hydrophobic solvents are unable to strip away the
water molecules associated with enzymes and in this process
enzymes retain the required degree of hydration to remain cat-
alytically active, whereas hydrophilic solvents, due to its water
loving nature strip away water molecules from the enzyme
complex which leads to catalytic deactivation. In the case of
toluene and cyclohexane as hydrophobic solvents, a positive
correlation between the activity of lipase and increased log P
values of the solvent could be seen.
2.3.3. Effect of reaction time
PCL and CRL catalyzed transesteriﬁcation reactions of (RS)-
10 were separately carried out in toluene and in cyclohexane,
respectively. Samples were collected periodically and centri-
fuged at 10,000g for ﬁve minutes to remove the enzyme prep-
aration. Conversion and enantiomeric excess were determined
using chiral HPLC. In the case of toluene as reaction medium,
it was observed that conversion and enantiomeric excess of
substrate increased with the reaction time. Maximum conver-
sion (C= 50%) and enantiomeric excess of substrate (97%)
were achieved after 36 h of reaction and thereafter no signiﬁ-
cant change in the rate of conversion and enantiomeric excess
was observed. The enantiomeric excess of the product was con-
stant, whereas, the enantiomeric ratio increased up to 36 h
(E= 277) and then it decreased with time (E= 100, at 48 h)and chemo-enzymatic synthesis of (RS)-, (R)-, and (S)-esmolol. Arabian
Table 1 Lipase-catalyzed transesteriﬁcation of (RS)-10 with vinyl acetate.a
Lipase Time (h) C (%)b ee (%)c ee (%)d Ee Conﬁguration of 11
CAL 12117 48 1.02 1.03 100 100 S
PCL 62279 48 51 100 96.07 100 S
CAL L4777 48 33.95 49.5 96.3 86.95 S
CRL 62316 48 55.48 85.59 68.67 14.39 R
CRL LY amino 48 54.15 74.55 63.13 9.65 R
ANL 62301 48 86.02 21.24 3.45 1.24 RS
CCL 62316 48 90.76 95.84 9.76 3.25 RS
MML 62350 48 87.50 96.67 13.81 3.91 RS
CRL 90860 48 92.56 53 4.26 1.54 RS
CRL L1754 48 90.79 35.13 3.56 1.35 RS
PPL 48 95.45 91.79 4.37 2.29 RS
a Conditions: (RS)-10 (20 mM) in toluene (4 mL) was treated with vinyl acetate (5.4 mmol) at 30 C in the presence of the enzyme (15 mg/mL).
b Conversions were calculated from the enantiomeric excess (ee) of (R)-10 (substrate S) and (S)-11 (product P) using the formula: conversion
(C) = eeS/(eeS + eeP).
c Enantiomeric excess of (R)/(S)-10 determined by HPLC analysis (Daicel Chiralcel OD-H column) 90:10; hexane: 2-propanol, 1 mL/min ﬂow
rate at 254 nm.
d Enantiomeric excess of (R)/(S)-11 determined by HPLC analysis (Daicel Chiralcel OD-H column) 90:10; hexane: 2-propanol, 1 mL/min ﬂow
rate at 254 nm.
e E values were calculated using the formula: E= [ln (1  C (1 + eeP)]/[ln (1  C (1-eeP)] (Straathof and Jongejan, 1997).
Table 2 The effect of organic solvent on the enantioselectivity in the resolution of (RS)-10 with lipase.a
Solvent Log P Cb (%) eesc (%) Eped (%) Ee
S-selective with PCL
Acetonitrile 0.33 37.57 46.02 76.47 11.75
1,4-Dioxane 1.1 48.2 7.82 8.4 1.27
t-Butyl methyl ether 1.35 52.07 100 92.04 100
Diethyl ether 0.85 49.11 83.56 86.6 36.44
Dichloromethane 1.25 34.19 44.69 86.01 20.62
Benzene 2 61.21 100 63.36 100
Heptane 4 42.75 70.52 94.42 73.68
Toluene 2.5 51 100 96.07 100
Cyclohexane 3.41 54.26 100 84.29 100
Hexane 3.5 49.2 90.1 93.04 85.78
Isooctane 4.5 46.1 76.46 89.4 41.23
R-selective with CRL 62316
Acetonitrile 0.33 36.88 20.99 35.93 2.58
1,4-Dioxane 1.1 32.16 15.76 33.23 2.31
t-Butyl methyl ether 1.35 51.69 71.37 66.69 10.47
Diethyl ether 0.85 56.09 30.34 23.76 2.12
Dichloromethane 1.25 22.72 9.39 31.95 2.12
Benzene 2 47.98 50.21 54.43 5.48
Heptane 4 84.19 71.14 13.36 2.36
Toluene 2.5 55.48 85.59 68.67 14.39
Cyclohexane 3.41 58.60 99.18 70.09 29.52
Hexane 3.5 77.90 75.68 21.47 3.09
Isooctane 4.5 72.36 83.27 31.81 4.52
a Conditions: (RS)-10 (20 mM) in organic solvent (4 mL) was treated with vinyl acetate (5.40 mmol) in the presence of lipase (15 mg/mL).
b Conversions were calculated from the enantiomeric excess (ee) of (R)-10 (substrate S) and (S)-11 (product P) for PCL and enantiomeric
excess (ee) of (S)-10 (substrate S) and (R)-11 (product P) for CRL using the formula: Conversion (C)=eeS/(eeS + eeP).
c Enantiomeric excess of (R)-10 (substrate S) for PCL and (S)-10 (substrate S) for CRL determined by HPLC analysis (Daicel Chiralcel OD-H
column) 90:10; hexane/2-propanol, 1 mL/min ﬂow rate at 254 nm.
d Enantiomeric excess of (R)-11 (product P) for PCL and (S)-11 (product P) for CRL determined by HPLC analysis (Daicel Chiralcel OD-H
column) 90:10; hexane/2-propanol, 1 mL/min ﬂow rate at 254 nm.
e E values were calculated using the formula: E= [ln (1  C (1 + eeP)]/[ln (1  C (1  eeP)] (Straathof and Jongejan, 1997).
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Figure 1 Course of reaction of PCL catalyzed transesteriﬁcation
of (RS)-10 in toluene.
Figure 3 Effect of enzyme concentration on PCL catalyzed
transesteriﬁcation of (RS)-10 in toluene.
Figure 4 Effect of enzyme concentration on CRL catalyzed
transesteriﬁcation of (RS)-10 in cyclohexane.
6 L. Banoth, U.C. Banerjee(Fig. 1). In the case of cyclohexane as reaction medium, it was
found that maximum conversion (C= 50.3%) and enantio-
meric excess of substrate (99.23) were achieved at 24 h and
thereafter, the rate of conversion and enantiomeric excess of
substrate increased. On the other hand, the enantiomeric ratio
and enantiomeric excess of the product were increased up to
24 h (E= 558.8) and thereafter it decreased with time (at
48 h, E= 29.52, Fig. 2). Prolonging the reaction time further
gave the advantage to the slower reacting enantiomer to con-
vert with a less satisfactory enantiomeric excess. Thus, 36
and 24 h were taken as optimum time for further study in tol-
uene and cyclohexane, respectively.
2.3.4. Effect of enzyme concentration
Enzyme concentration affects the rate of conversion as well as
the enantiomeric excess of the product. To investigate the
effect of enzyme concentration on conversion, enantiomeric
excess and enantiomeric ratio, resolution was carried out using
different concentrations of PCL and CRL preparations (10,
20, 30, 40 and 50 mg/mL) in toluene and cyclohexane, respec-
tively. It was observed that in the case of toluene, with the
increase in enzyme concentration, the conversion increased
up to a certain level after which there was no signiﬁcant change
in conversion. In toluene as the reaction medium, maximum
enantiomeric ratio (807.85) and enantiomeric excesses of the
product (98.73) and substrate (98.83) with a conversion ofFigure 2 Course of reaction of CRL catalyzed transesteriﬁcation
of (RS)-10 in cyclohexane.
Please cite this article in press as: Banoth, L., Banerjee, U.C. New chemical
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.03.01150.02% were obtained with 30 mg/mL PCL enzyme prepara-
tion (Fig. 3). In the case of cyclohexane as a reaction medium,
the maximum enantiomeric ratio (558.8) and enantiomeric
excesses of the product (98.03) and substrate (99.23) with
50.30% conversion were achieved with 20 mg/mL CRL
enzyme preparation (Fig. 4). For all the subsequent experi-
ments, enzyme concentrations of 20 and 30 mg/mL of CRL
and PCL in cyclohexane and toluene were used, respectively.
2.4. Deacylation of (RS)/(R)/(S)-11
The (RS)/(R)/(S)-10 alcohol from the acetylated intermediate
(RS)/(R)/(S)-11 was formed by deacetylation in aqueous
K2CO3 at rt (Khan et al., 2001) (Scheme 6).
2.5. Synthesis of (S)-esmolol 1
(R)-10 [obtained by ring opening of (S)-2 with acetyl chloride
and water, deacetyaltion of (R)-11 and the enzymatic kinetic
resolution of (RS)-10] was treated with isopropylamine in
methanol under reﬂux overnight (Zaidlewicz et al., 2005) to
afford (S)-esmolol 1 (Scheme 7).
(S)-10 [obtained by ring opening of (R)-2 with acetyl chlo-
ride, deacetyaltion of (S)-11 and the enzymatic kinetic resolu-
tion of (RS)-10] was treated with isopropylamine in methanol
under reﬂux overnight23 to afford (R)-esmolol 1 (Scheme 8).and chemo-enzymatic synthesis of (RS)-, (R)-, and (S)-esmolol. Arabian
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The efﬁcient chemical and chemoenzymatic synthesis of the
highly enantiomerically enriched cardiovascular drug esmolol
is reported in this study with an improved overall yield (61–
76%) and higher enantiomeric excess (92–98%). Commercial
lipases such as PCL and CRL offered complementary selectiv-
ity for the transesteriﬁcation of RS-10 with vinyl acetate to
afford the key intermediate (R)/(S)-10 for (R)/(S)-11 which is
required for the synthesis of enantio-pure (R)/(S)-esmolol.
The enzymatic switch toward the synthesis of enantiodivergent
esmolol is a good example in the green synthesis. For the efﬁ-
cient chemical synthesis of (RS)/(R)/(S)-esmolol, a new syn-
thetic route is proposed.
4. Experimental
4.1. General experimental details
4.1.1. Analysis
Enzymatic reactions were carried out in an incubator (Kuhner,
Switzerland) at 200 rpm. 1H NMR and 13C NMR spectra were
obtained with Bruker DPX 400 (1H 400 MHz and 13C
100 MHz), chemical shifts were expressed in d units relative
to the tetramethylsilane (TMS) signal as an internal reference
in CDCl3. IR spectra (wave number in cm
1) were recorded
on Nicolet FT-IR impact 400 instruments as KBr pellets for
solid samples or neat for liquid. Merck plates were used for
the analytical TLC of all reactions. SRL silica gel (60–120
mesh) was used in column chromatography. LC–MS analysis
was carried out on Finninganmat LCQ instrument (USA)
using a C-18 hypersil ODS (4.6 mm · 15 mm, 5 m) column.
Optical rotation was measured in a Rudolph, AutopolR IV
polarimeter. The enantiomeric excesses (ee) were determinedPlease cite this article in press as: Banoth, L., Banerjee, U.C. New chemical a
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.03.011by HPLC (Shimadzu LC-10AT ‘pump’, SPD-10A UV–VIS
detector) using a Chiralcel OD-H column (0.46 mm · 250 mm;
5 lm, Daicel Chemical Industries, Japan) at 254 nm. The con-
ditions were: mobile phase, hexane: 2-propanol (90:10); ﬂow
rate, 1 ml/min; column temperature, 25 C.
4.1.2. Reagents
(RS)-epichlorohydrin, (R)-epichlorohydrin, (S)-epichlorohy-
drin, 2-hydroxy benzonitrile, and the lipase preparations from
C. antarctica (CAL L4777) C. rugosa (CRL 62316) C. rugosa
(CRL 90860) C. rugosa L8525, C. rugosa L-1754 (CRL
L1754), C. cylindracea (CCL 62316), A. niger (ANL 62301)
and porcine pancreas lipase (PPL) were purchased from
SIGMA (USA). The analytical or commercial grade solvents
were procured from various commercial sources. HPLC grade
solvents were obtained from J.T. Baker, Rankem and Merck
Ltd. Immobilized lipase in sol–gel-Ak from P. cepacia (PCL
62279), immobilized lipozyme from M. miehei (MML 62350),
lipase A and C. antarctica (CAL 12117) lipase were purchased
from Fluka and lipase AY ‘‘Amano’’ 30 (CRL LY amino)
was purchased from Amano Chem Ltd. They were used with-
out any further treatment. The strains 5b1, 5b2, 5a1, 1b1 (N),
5d1, 1b1 used were previously isolated from soil in our labora-
tory for the resolution of (RS)-3-[5-(4-ﬂuoro-phenyl)-5-
hydroxy-pentanoyl]-4-phenyl-oxazolidin-2-one, an intermedi-
ate for ezitimibe synthesis (Singh et al., 2012). These isolates
were maintained on selective media at 4 C.4.2. Synthesis of (RS)/(R)/(S)-methyl 3-(4-((oxiran-2-
yl)methoxy)phenyl) propanoate (2)
To the mixture of 3 (3.6 g, 20 mmoL) and K2CO3 (11.04 g, 40
mmoL) in anhydrous MeCN (100 mL) was added (RS)-4
(3.5 mL, 30 mmoL) and the reaction mixture was heated undernd chemo-enzymatic synthesis of (RS)-, (R)-, and (S)-esmolol. Arabian
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and washed with MeCN and the combined organic layer was
concentrated under vacuum, and the residue was puriﬁed using
a silica gel (60–120 mesh) column and eluting with ethyl ace-
tate: hexane (15:85) to afford (RS)-2. A light yellow liquid
(90% yield, 4.24 g); 1H NMR (400 MHz, CDCl3): d 2.55–
2.57 (m, 2H) 2.69–2.71 (m, 1H), 2.81–2.91 (m, 3H), 3.26–
3.33 (m, 1H), 3.66 (s, 3H), 3.94–3.95 (m, 1H), 4.11–4.15 (dd,
1H), 7.01–7.05 (m, 2H), 7.25–7.29 (m, 2H); 13C NMR
(100 MHz, CDCl3): d 34.5, 35.8, 45.3, 49.8, 52.1, 70.0, 115.2,
128.7, 131.8, 156.8, 172.3; MS (APCI) (m/z) 237.41.
(R)-2: a light yellow liquid, (87% yield, 1.02 g); 94% ee. [a]D
20
4.42 (c 1.0, CHCl3) [lit [a]D20 4.42 (c 1.0, CHCl3), op 94%].
(S)-2: a light yellow liquid (89% yield, 1.05 g); 95% ee. [a]D
20
+4.46 (c 1.0, CHCl3) [lit [a]D
20 +4.46 (c 1.0, CHCl3), op 95%].
4.3. Synthesis of (RS)/(R/)(S)-methyl-3-(4-(3-chloro-2-
hydroxypropoxy)phenyl)propanoate (10)
To a stirred solution of (RS)-2 (4.73 g, 20 mmoL in 100 mL
(DCM: water::50:50) containing acetyl chloride (2.35 g,
30 mmoL) was added. The resultant reaction mixture was stir-
red at room temperature for 2 h and on completion of the reac-
tion (TLC), the mixture was extracted with DCM (50 mL) and
washed with water. The organic layer was separated and dried
on Na2SO4 and concentrated under vacuum. The residue was
puriﬁed by passing through a silica column (60–12 mesh) and
eluting with ethyl acetate: hexane (15:85) to obtain (RS)-10.
The (RS)-10 was then subjected to chiral HPLC analysis using
chiralcel OD-H column and the two enantiomers were eluted
after 23 min and 25 min (90:10 hexane: 2-propanol) respec-
tively and were present in a ratio of 49:51. Following a similar
procedure (R)-10 and (S)-10 were prepared from (S)-2 and (R)-
2, respectively.
(RS)- 10: a light yellow liquid (92% yield, 5 g); 1H NMR
(400 MHz, CDCl3): d 2.59 (t, J= 7.96 Hz, 2H), 2.89 (t,
J= 9.08 Hz, 2H), 3.66 (s, 3H), 3.69–3.79 (m, 2H), 4.02–4.21
(m, 3H), 6.83–6.86 (m, 2H), 7.10–7.13 (m, 2H); 13C NMR
(100 MHz, CDCl3): d 30.1, 35.9, 45.9, 51.6, 68.5, 69.9, 114.6,
129.3, 133.5, 156.7, 173.4. MS (APCI) (m/z): 273.81;
(R)-10: a light yellow liquid, (92% yield, 1.25 g); The prod-
uct was then subjected to chiral HPLC analysis using a chiral
OD-H column, the two enantiomers were eluted at tS = 25
min and tR = 23 min (90:10::hexane: 2-propanol) with peak
areas of 3 and 97%, respectively, (94% ee).
(S)-10: a light yellow liquid, (91% yield, 1.24 g); The prod-
uct was then subjected to chiral HPLC analysis using a chiral
OD-H column, the two enantiomers were eluted at tS = 25
min and tR = 23 min (90:10::hexane: 2-propanol) with peak
areas of 96.5 and 3.5%, respectively, (93% ee).
4.4. Synthesis of (RS)/(R/)(S)- methyl-3-(4-(2-acetoxy-3-
chloropropoxy)phenyl)propanoate (11)
(RS)-11 was synthesized chemically by treating of (RS)-10
(0.5 g, 2 mmol) with Ac2O (0.3 g mL, 3 mmoL) in the presence
of ZrCl4 (5 mg, 2 mol%) in MeCN at rt withmagnetic stirring.
After disappearance of (RS)-10 (TLC, 2 h), water was added
into the reaction mixture and washed with NaHCO3. The
organic layer was then separated and concentrated under vac-
uum to afford (RS)-11 as a yellow liquid (95% yield, 0.59 g);Please cite this article in press as: Banoth, L., Banerjee, U.C. New chemical
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.03.0111H NMR (400 MHz, CDCl3): d 2.12–2.16 (s, 3H), 2.59 (t,
J= 7.96 Hz, 2H), 2.89 (t, J= 9.08 Hz, 2H), 3.66 (s, 3H),
3.74–3.84 (m, 2H), 4.05–4.26 (m, 3H), 6.86–6.89 (m, 2H),
7.10–7.13 (m, 2H); 13C NMR (100 MHz, CDCl3): d 21.4,
30.1, 35.9, 45.9, 51.7, 68.6, 69.9, 114.6, 129.4, 133.5, 156.7,
170.2 173.5; MS (APCI) (m/z): 315.85. (RS)-11 was subjected
to chiral HPLC analysis using a chiralcel OD-H column and
the two enantiomers were eluted after 32 min and 42 min
(90:10 hexane: 2-propanol), respectively and were present in
a ratio of 49.9:50.1. Following a similar procedure (R)-11
and (S)-11 were prepared from (R)-10 and (S)-10, respectively.
(R)-11: a yellow liquid, (93% yield, 0.58 g); The product
was then subjected to chiral HPLC analysis using a chiral
OD-H column, the two enantiomers were eluted at tR = 42 -
min and tS = 32 min (90:10::hexane: 2-propanol) with peak
areas of 97% and 3%, respectively, (94% ee).
(S)-11: a yellow liquid (92% yield, 0.57 g); The product was
then subjected to chiral HPLC analysis using chiral OD-H col-
umn, the two enantiomers were eluted at tR = 42 min and
tS = 32 min (90:10::hexane: 2-propanol) with peak areas of
3.5% and 96.5%, respectively, (93% ee).
4.5. Enantioselective transesteriﬁcation of (RS)-10
In a 10 mL round bottomed ﬂask containing magnetic beads, a
mixture of (RS)-10 (20 mM) in 4 mL toluene and 5.40 mmoL
vinyl acetate was placed. Lipases from different sources (com-
mercial lipase from lipase A, C. antarctica, C. rugosa L8525, C.
rugosa L-1754, C. cylindracea, A. niger, porcine pancreas and
AY ‘‘Amano’’ 30 and crude lipase from strains 5b1, 5b2,
5a1, 1b1 (N), 5d1, 1b1 laboratory strains (Singh et al., 2012))
were used to carry out the reaction. The round bottomed ﬂask
was capped and placed on a magnetic stirrer which was main-
tained at room temperature. Immobilized lipase in sol–gel-Ak
from P. cepacia, immobilized lipozyme from M. miehei, lipase
acrylic resin from C. antarctica, were individually taken into
separate 10 mL conical ﬂask, the ﬂasks were capped and
placed in shaker which was maintained at 25 C (200 rpm).
Samples (300 lL) were withdrawn from the reaction mixture
and conversion and the enantiomeric excess of the reaction
were monitored by HPLC.
4.6. Optimization of transesteriﬁcation reaction
The effect of different organic solvents such as MeCN, 1.4
dioxane, tert-butyl methyl ether, diisopropyl ether, diethyl
ether, DCM, benzene, heptane, isooctane and toluene on the
transesteriﬁcation of (RS)-10 was observed. The optimum time
was determined by carrying out the reaction and collecting the
samples at various time intervals. Various enzyme concentra-
tions (10, 20, 30, 40 and 50 mg/mL) were used with a ﬁxed sub-
strate concentration (20 mM). The samples were taken at
regular time intervals and analyzed for conversion and enanti-
oselectivity of the transesteriﬁcation reaction.
4.7. Preparative-scale transesteriﬁcation reaction
The resolution of (RS)-10 was carried out in preparative
scale in optimized condition. The reaction was performed by
subjecting 50 mL (20 mmoL substrate, 0.28 g) of the reaction
mixture to resolution by PCL and CRL lipase at 30 C usingand chemo-enzymatic synthesis of (RS)-, (R)-, and (S)-esmolol. Arabian
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tively. When the transformation was ca. 50% (36 h, 50.02%
conversion for PCL and 24 h, 50.3% conversion for CRL)
the reaction contents were ﬁltered off and the enzyme prepara-
tion was washed with solvent. The solvent was evaporated
under reduced pressure and the resulting dried residue was
subjected to ﬂash chromatography using ethyl acetate:hexane
(15:85) (v/v) as mobile phase. It was observed with PCL that
after 36 h the isolated yield of (R)-10 was 46%, 0.128 g, with
enantiomeric excess of 98.83% (Chiralcel OD-H) and that of
(S)-11 was 47%, 0.151 g with enantiomeric excess of 98.73%
(Chiralcel OD-H). It was observed with CCL that after 24 h
the isolated yield of (S)-10 was 46.5%, 0.13 g with enantio-
meric excess of 99.23%, (Chiralcel OD-H) and that of (R)-11
was 47%, 0.151 g with enantiomeric excess of 98.03%, (Chiral-
cel OD-H).4.7.1. For PCL catalyzed reaction
(R)-10: a light yellow liquid, (46% yield, 0.128 g); The product
was then subjected to chiral HPLC analysis using chiralcel
OD-H column, the two enantiomers were eluted at tS = 25 -
min and tR = 23 min (90:10::hexane: 2-propanol) with peak
areas of 0.59% and 99.41%, respectively, (98.83% ee).
(S)-11: a yellow liquid (47% yield, 0.151 g); The product
was then subjected to chiral HPLC analysis using a chiralcel
OD-H column, the two enantiomers were eluted at tR = 42 -
min and tS = 32 min (90:10:: hexane: 2-propanol) with peak
areas of 0.61% and 99.38%, respectively, (98.73% ee).
4.7.2. For CRL catalyzed reaction
(S)-10: a light yellow liquid, (46.5% yield, 0.13 g); The product
was then subjected to chiral HPLC analysis using chiralcel
OD-H column, the two enantiomers were eluted at tS = 25 -
min and tR = 23 min (90:10::hexane: 2-propanol) with peak
areas of 99.6% and 0.4%, respectively, (99.23% ee).
(R)-11: a yellow liquid, (47% yield, 0.151 g); The product
was then subjected to chiral HPLC analysis using chiralcel
OD-H column, the two enantiomers were eluted at tR = 42 -
min and tS = 32 min (90:10::hexane: 2-propanol) with peak
areas of 99% and 1%, respectively, (98.03% ee).4.8. Deacylation of (RS)/(R)/(S)-11
A solution of K2CO3 (0.27 g, 2 mmol) in distilled water (1 ml)
30 was added to a solution of 11 (0.31 g, 1 mmol) in methanol
(5 ml) and the resultant reaction mixture was allowed to stir
for 2 h at rt. After completion of the reaction the reaction mix-
ture was extracted with EtOAc (3 · 15 ml) and water (10 ml).
The combined organic extracts were dried over Na2SO4 and
concentrated under vacuum to obtain the crude which was
puriﬁed by silica gel column chromatography (100–200 mesh)
to obtain the corresponding alcohol.
(RS)-10: a light yellow liquid (92% yield, 0.251 g);
(R)-10: a light yellow liquid, (90% yield, 0.245 g); The prod-
uct was then subjected to chiral HPLC analysis using chiralcel
OD-H column, the two enantiomers were eluted at tS = 25 -
min and tR = 23 min (90:10::hexane: 2-propanol) with peak
areas of 1.25% and 98.75%, respectively, (97.5% ee).
(S)-10: a light yellow liquid, (91% yield, 0.248 g); The prod-
uct was then subjected to chiral HPLC analysis using a chiral-Please cite this article in press as: Banoth, L., Banerjee, U.C. New chemical a
Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.03.011cel OD-H column, the two enantiomers were eluted at
tS = 25 min and tR = 23 min (90:10::hexane: 2-propanol) with
peak areas of 99% and 1%, respectively, (98% ee).
4.9. Synthesis of (RS)-1
(RS)-10 (0.27 g, 1 mmoL) was treated with isopropylamine in
methanol (10 mL) in the presence of Et3N (0.1 g, 1 mmoL)
under reﬂux condition for 8 h and on completion of the reac-
tion (TLC), the mixture was diluted with ethyl acetate (15 mL)
and washed with water. The organic layer was separated and
dried on Na2SO4 and concentrated under vacuum. The residue
was puriﬁed by performingcolumn chromatography of silica
gel (60–12 mesh) and eluting with ethyl acetate: hexane
(15:85) to obtain (RS)-1.
(RS)-1: a white solid (92% yield, 0.27 g); 1H NMR
(400 MHz, CDCl3): d 1.8 (s, 6H), 2.47 (t, J= 6.4, 2H) 2.62–
2.68 (m, 1H), 2.82–2.91 (m, 4H), 3.56 (s, 3H), 3.75–3.93 (m,
3H) 6.78 (d, J= 6.4, 2H), 7.12(d, J= 6.2, 2H): 13C NMR
(100 MHz, CDCl3): d 21.24, 27.61, 31.81, 45.21, 46.02, 48.23,
66.56, 69.53, 112.97, 125.76, 129.35, 152.98, 163.87; MS
(APCI) (m/z): 296.49.
4.10. Synthesis of (S)/(R)-1
(R)/(S)-10 (0.27 g, 1 mmoL) was treated with isopropylamine
in methanol (10 mL) in the presence of Et3N (0.1 g, 1 mmoL)
under reﬂux condition for 8 h and on completion of the reac-
tion (TLC), the mixture was diluted with ethyl acetate and
washed with water. Ethyl acetate layer was separated and dried
on Na2SO4 and it was concentrated under vacuum. The resi-
due was puriﬁed by performing silica gel (60–12 mesh) column
chromatography and eluting with ethyl acetate: hexane (15:85)
to obtain (S)/(R)/-1.
4.10.1. For enzymatic kinetic resolution directly from
enzymatically prepared (R)/(S)-10
(S)-1: a yellow liquid, (90% yield, 0.266 g); The product was
then subjected to chiral HPLC analysis using a chiralcel OD-
H column, the two enantiomers were eluted at tS = 26.5 min
and tR = 30.8 min (90:10::hexane: 2-propanol) with peak
areas of 99% and 1%, respectively, (98% ee).
(R)-1: a yellow liquid, (89% yield, 0.263 g); The product
was then subjected to chiral HPLC analysis using chiralcel
OD-H column, the two enantiomers were eluted at tS = 26.5
min and tR = 30.8 min (90:10::hexane: 2-propanol) with peak
areas of 1% and 99%, respectively, (98% ee).4.10.2. For enzymatic kinetic resolution via by deacylation of
enzymatically prepared (R)/(S)-11
(S)-1: a yellow liquid, (91% yield. 0.269 g); The product was
then subjected to chiral HPLC analysis using a chiralcel OD-
H column, the two enantiomers were eluted at tS = 26.5 min
and tR = 30.8 min (90:10::hexane: 2-propanol) with peak
areas of 98.5% and 1.5%, respectively, (97% ee).
(R)-1: a yellow liquid, (90% yield. 0.266 g); The product
was then subjected to chiral HPLC analysis using a chiralcel
OD-H column, the two enantiomers were eluted at tS = 26.5
min and tR = 30.8 min (90:10::hexane: 2-propanol) with peak
areas of 1.25% and 98.75%, respectively, (97.5% ee).nd chemo-enzymatic synthesis of (RS)-, (R)-, and (S)-esmolol. Arabian
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(S)-1: a yellow liquid, (92% yield, 0.272 g); The product was
then subjected to chiral HPLC analysis using chiralcel OD-H
column, the two enantiomers were eluted at tS = 26.5 min
and tR = 30.8 min (90:10::hexane: 2-propanol) with peak
areas of 96.5% and 3.5%, respectively, (93% ee).
(R)-1: a yellow liquid, (91% yield, 0.269 g); The product
was then subjected to chiral HPLC analysis using a chiralcel
OD-H column, the two enantiomers were eluted at tS = 26.5 -
min and tR = 30.8 min (90:10::hexane: 2-propanol) with peak
areas of 4% and 96%, respectively, (92% ee).
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